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Purpose: There are no evidence-based guidelines for volume replacement during surgical 
procedures such as laparoscopic cholecystectomy. However, the administration of a restrictive 
volume of crystalloids could be more cost-effective and safe. This trial aimed to determine the 
effectiveness and safety of a restrictive regimen of crystalloids in patients during laparoscopic 
cholecystectomy by analyzing its cost-effectiveness and 1-year morbidity rate.
Patients and methods: In this randomized, prospective study, patients were assigned to one of 
three groups based on the volume of fluid administered: the restrictive group received 1 mL/kg/hr, 
the low liberal group received 5 mL/kg/hr, and the high liberal group received 15 mL/kg/hr of 
Ringer’s solution intraoperatively. There were 40 patients in each group. Each patient’s hemo-
dynamic parameters and laboratory values (arterial blood gas and lactate levels) were measured 
together with their consumption of crystalloids, volatile anesthetics, and analgesics.
Results: Analysis of the hemodynamic and laboratory parameters revealed no signs of global 
hypoperfusion in any of the groups analyzed. There was no significant difference in the duration 
of surgery and anesthesia, but the consumption of crystalloids, volatile anesthetics, and opioids 
was significantly lower in the restrictive group, compared with the low and high liberal groups. 
Although there was no significant difference in the 1-year morbidity among the groups, heart 
failure was observed in one patient in the high liberal group in the early postoperative period.
Conclusion: Restrictive fluid therapy during laparoscopic cholecystectomy is justified, safe, 
and more cost-effective than other options.
Keywords: cholecystectomy, laparoscopic, crystalloid solutions, fluid therapy, hemodynamics, 
cost–benefit analysis, morbidity, mortality
Introduction
The maintenance of adequate tissue perfusion is the objective of intravenous fluid 
therapy. The optimal type, volume, and dosage of perioperative intravenous fluids 
have been extensively studied, yet no consensus on perioperative fluid management 
has been reached.1 Crystalloids are recommended for elective surgical procedures 
whereas colloids are recommended for patients with acute bleeding.2,3 Traditional 
fluid therapy consists of significantly higher doses of intravenous fluids than the 
clinical losses that occur because of tissue trauma or surgery. This practice can lead 
to hypervolemia and tissue edema,3 which can cause cardiopulmonary complications, 
anastomotic insufficiency, longer hospital stays, mechanical ventilation, endothelial 
glycocalyx damage, and higher mortality rates.4 Hypervolemia must be avoided during 
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elective surgical procedures as it breaks down the integrity 
of the endothelial glycocalyx, causing interstitial edema with 
poor outcomes.2,3
Patients who receive a lower volume of intravenous 
fluids during and after colorectal surgery have fewer post-
operative complications.3 In addition, lower volumes lead 
to an earlier return of bowel motion and flatulence, earlier 
resumption of enteral nutrition, and shorter hospital stays 
after major colorectal surgery.3,5 In contrast, patients under-
going laparoscopic cholecystectomy who receive restrictive 
fluid replacement have higher rates of postoperative nausea 
and vomiting.6
We hypothesized that a restrictive dose of Ringer’s 
solution7 will not adversely affect the patients’ global hemo-
dynamics during laparoscopic cholecystectomy and will be 
safer and more cost-effective than other options.
Patients and methods
This prospective, two-arm, parallel, randomized study was 
conducted from March 23, 2015 to November 30, 2017. 
It was approved by the Ethics Committee of Karlovac 
General Hospital, Croatia, on March 16, 2015 (protocol no 
01-12-24/1) and was registered in the German Clinical Trials 
Register (DRKS) under the unique identification number 
DRKS00007904.
The study included patients with gallstones who were 
scheduled for laparoscopic cholecystectomy. All patients 
provided written informed consent before participating in 
the study. The study was conducted according to the guide-
lines set forth by the World Medical Association, as outlined 
in the Declaration of Helsinki: Ethical Principles for Medical 
Research Involving Human Subjects.
inclusion and exclusion criteria
This study included 120 patients of American Society of 
Anesthesiology (ASA) classes I and II who were scheduled 
for laparoscopic cholecystectomy. Patients younger than 18 
or older than 75 years of age, those with local and systemic 
inflammatory or immune diseases, and those with severe 
functional organ impairment or hematologic or malignant 
diseases were excluded. A flowchart indicating the final 
sample, including the number of excluded patients and the 
reasons for exclusion, is presented in Figure 1. There were 
no statistically significant differences in age, sex, or body 
mass index among the patient groups.
Objectives of the study
The objective of the current study was to determine the 
effectiveness and safety of a restrictive regimen of crystal-
loids during laparoscopic cholecystectomy, according to 
hemodynamic parameters, arterial blood gas (ABG), lactate 
concentrations, critical outcomes8 (respiratory and cardiac 
complications, renal failure, etc.), early postoperative sur-
gical complications, length of hospital stay, 1-year morbidity, 
and mortality. The second objective was to determine the 
cost-effectiveness of various volumes of crystalloids.
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Figure 1 Flow chart of the study.
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Restrictive group and two liberal groups 
of patients
Patients were randomly allocated to one of two 40-person 
groups by the computer program Sealed Envelope® (Sealed 
Envelope Ltd, London, UK). Patients allocated to the 
restrictive group received 1 mL/kg/hr9 of Ringer’s solution 
intraoperatively whereas those allocated to the low liberal 
group received 5 mL/kg/hr. The dose in the low liberal 
group was equal to the proposed dose for moderate tissue 
trauma (ie, cholecystectomy): 4–6 mL/kg/hr10 and did not 
differ much from the usual dose of crystalloids given during 
gallbladder surgery.
Due to the routine clinical practice in Croatia and 
worldwide, where a larger volume of crystalloid solutions 
(15 mL/kg/hr) is usually used, a 40-person high liberal 
group was additionally analyzed. It was cross-matched 
with the restrictive group. Patients allocated to the high 
liberal group received 15 mL/kg/hr of Ringer’s solution 
intraoperatively. The survey was conducted in the operating 
room and at the Department of Abdominal Surgery, General 
Hospital Karlovac, Croatia. All 120 patients received 7.5 mg 
midazolam orally 30 minutes before surgery. In the recovery 
room, an intravenous line was placed in each patient and an 
infusion of isotonic Ringer’s solution7 using Infusomat was 
started in accordance with the protocol.
Operations were conducted under general anesthesia. 
For co-induction of general anesthesia, 2.5 mg midazolam 
was intravenously administered to all patients to reduce 
the dose of other anesthetics and preserve hemodynamic 
stability. At 3 minutes after co-induction, anesthesia was 
induced by intravenous hypnotic thiopental at a dose of 
5 mg/kg. For muscle relaxation, rocuronium bromide at a 
dose of 0.6 mg/kg was administered. After the induction 
of anesthesia, the patient was endotracheally intubated and 
mechanically ventilated by the anesthetic apparatus Avance 
CS2 (FIN-00031 GE; GE Healthcare, Finland). Anesthesia 
was maintained by a mixture of oxygen and air and the 
volatile anesthetic sevoflurane. For analgesia, opioid fentanyl 
in 2–3 µg/kg doses was given during operation and, for 
postoperative analgesia, 25–100 mg tramadol hydrochloride 
and 1.25–2.5 g metamizole were given intravenously. After 
extubation, patients were transferred to the recovery room.
hemodynamic monitoring
Hemodynamic monitoring of each patient was done with 
impedance cardiography (ICON; Osypka Medical GmbH, 
Berlin, Germany; BioZ® ICG Impedance Cardiography; 
CardioDynamics, San Diego, CA, USA; Solar GE Medical 
System Information Technologies, Milwaukee, WI, USA). 
Systolic blood pressure (SAP), diastolic blood pressure 
(DAP), mean arterial pressure (MAP), heart rate, cardiac index 
(CI), stroke volume index (SVI), systemic vascular resistance 
index (SVRI), peripheral oxygen saturation, and electrocar-
diography were recorded before inducing anesthesia (T0), 
immediately after intubation (T1), at the creation of pneumo-
peritoneum (T2), and immediately after surgery (T3).
Blood sampling
Blood samples for ABG analysis and lactate concentration 
were taken before the induction of anesthesia (T0), at the 
creation of pneumoperitoneum (T1), and immediately after 
surgery (T2).
Mortality and morbidity assessment
We used the Simplified Acute Physiology Score (SAPS II) as 
a prognostic score for calculating predictive mortality.11 More-
over, we assessed critical outcomes8 during the 30-day post-
operative period, early postoperative surgical complications, 
length of hospital stay, 1-year morbidity, and mortality.
Calculation of the anesthetic and 
crystalloid consumption
We assessed the consumption of crystalloids, volatile 
anesthetics, and opioids by measuring the exact doses that 
were administered during each operation and comparing 
statistical differences between the groups. The consumption 
of volatile anesthetics was calculated using Dion’s method.12 
We used the following formula: V = (P*F*T*M)/(2412*d), 
where V is the consumption of sevoflurane in milliliters; 
P is the vaporizer dial concentration in percentage; F is the 
total fresh gas flow in liter per minute; T is time, for which 
the concentration P was set in minutes; M is the molecular 
mass of sevoflurane in grams; and d is the density of liquid 
sevoflurane in gram per milliliter.13,14 The fixed variables used 
were as follows: F (total fresh gas flow) was set at 4 L/min 
for maintenance of anesthesia; M (molecular mass of sevo-
flurane) was 200.055 mg; and d (density of sevoflurane at 
21°C) was 1.52 g/mL.14 Substituting the fixed variables, the 
equation can be rewritten for induction as follows: 0.2184 
(T*P) for T (time) in minutes.14 The consumption of opioids 
and crystalloids was calculated from the anesthesia charts.
statistical analysis
Statistical analysis of the quantitative data was carried 
out by examining the normality of distributions and using 
Shapiro–Wilk’s test and a normality histogram. Descriptive 
statistics were used for presenting demographic and surgical 
data. Because of the abnormal distributions of laboratory 
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values and hemodynamic variables, nonparametric tests were 
applied. Data were presented as a median and interquartile 
range from the 25th to 75th quartiles. Friedman’s test and 
a post hoc Wilcoxon rank sum test were used to compare 
various time points within the same group. For the statistical 
comparison of data between the groups, a Kruskal–Wallis test 
and post hoc Mann–Whitney U test were used. Chi-square 
test was used for comparison of critical outcomes, early 
postoperative surgical complications, and 1-year morbidity. 
The G*Power program (G*Power 3.1.9.2 Software 2014; 
University of Düsseldorf, Düsseldorf, Germany) was used 
to estimate sample size. A predictive sample size was calcu-
lated for the nonparametric Wilcoxon and Mann–Whitney 
U tests. The expected difference between the two means of 
the cardiac index was 0.85, and the SDs were 0.7 and 0.6. 
The total sample size was 78 respondents, and there were 39 
respondents per group, with a two-sided confidence interval 
of 0.95 and a desired power of 0.90. Data were recorded in 
Excel (Microsoft Office Excel 2003; Microsoft, Redmond, 
WA, USA). Statistical processing was carried out with SPSS 
22 (IBM Corporation, Armonk, NY, USA). The results are 
presented in tables and graphs. Using Bonferroni corrections, 
p-values less than 0.017 were considered statistically signifi-
cant for comparing four different time points, and p-values 
less than 0.025 were considered statistically significant for 
comparing values between the different groups.
Results
Demographic, anesthesiologic, and 
surgical data
The demographic, anesthesiologic, and surgical data of 
this study population are shown in Table 1. There was a 
significant difference in blood loss between the restrictive and 
high liberal groups (p = 0.003). The total volume of infusion 
solutions that patients received during surgery was 99 mL 
in the restrictive group, 474 mL in the low liberal group, 
and 1,485 mL in the high liberal group. The intraoperative 
fluid balance was calculated by subtracting the volume of 
blood loss, urine output, and insensible perspiration from 
the infused volume. There was a significant difference 
in volume infused, urine output, and intraoperative fluid 
balance on comparisons between the restrictive and the low 
liberal, as well as the restrictive and the high liberal, groups 
as shown in Table 1 (p , 0.001). There was no statistically 
significant difference in the length of hospitalization between 
the groups.
hemodynamic changes in saP, DaP, MaP, 
and heart rate
The SAP, DAP, MAP, and heart rate values in the three patient 
groups are shown in Figure 2. The SAP values decreased sig-
nificantly from T0 to T1 in the restrictive [median: 133 (inter-
quartile range: 116–154) mmHg vs 119 (99–137) mmHg, 
p , 0.001] and low liberal groups [141 (119–153) mmHg vs 
114 (101–129) mmHg, p , 0.001; Figure 2A]. In the high 
liberal group, SAP values did not significantly change at any 
time point. SAP was significantly lower in the restrictive group 
than in the high liberal group at T1 [119 (99–137) mmHg 
vs 135 (119–151) mmHg, p = 0.016; Figure 2A]. DAP and 
MAP values did not change significantly within or between 
the groups (Figure 2B and C). Heart rates are illustrated in 
Figure 2D. Statistically significant increases in heart rate 
were observed in the restrictive and high liberal groups from 
T0 to T1 [74 (69–81) beats/min vs 85 (75–99) beats/min, 
Table 1 Baseline demographics, anesthesiologic, and surgical data
Variable Restrictive group 
(n = 40)
Low liberal group 
(n = 40)
High liberal group 
(n = 40)
p-values (p1/p2)
sex (female/male) 27/13 26/14 28/12 0.78/0.77
age (years) 50 (40.3–62.5) 58 (44.5–69) 56.5 (42.3–66.5) 0.094/0.387
Preoperative weight (kg) 82 (74–93.5) 79.5 (70–92) 80.5 (75–92) 0.212/0.234
height (cm) 167 (160–175) 166 (160–170) 165 (161–172) 0.22/0.24
Body mass index (kg/m2) 29 (27–31.6) 27 (25–32) 28 (26–33) 0.99/0.64
Body surface area (m2) 1.9 (1.8–2.1) 1.8 (1.7–2) 1.9 (1.7–2) 0.29/0.59
Duration of surgery (minutes) 57 (50–65) 57.5 (48.8–71) 58.5 (50–73.3) 0.75/0.72
Duration of anesthesia (minutes) 70 (60–80) 70 (60–92.5) 70 (63.8–100) 0.49/0.47
Blood loss (ml) 40 (25–50) 40 (20–56) 60 (35–86) 0.94/0.003
Fluids infused intraoperatively (ml) 99 (73–113) 474 (393–602) 1,485 (1,222–1,970) 0.000/0.000
Diuresis intraoperatively (ml) 38 (30–40) 55 (45–66) 90 (74–100) 0.000/0.000
Fluid balance intraoperatively (ml) −30 (−38 to −70) 296 (247–423) 1,209 (999–1,659) 0.000/0.000
Days of hospitalization 3 (3–4) 3 (3–4) 3 (3–4) 0.054/0.238
Notes: Data are shown as median (25–75 interquartile range). p1 , 0.025 presents statistical differences between the restrictive group and the low liberal group; p2 , 0.025 
presents a statistical difference between the restrictive group and the high liberal group.
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p , 0.001; and 68 (61–79) beats/min vs 79 (68–94) beats/min, 
p , 0.001, respectively]. The heart rate was significantly faster 
in the restrictive group than in the low liberal group at T1 
[85 (75–99) beats/min vs 75 (64–89) beats/min, p = 0.003]. 
The heart rate was significantly faster in the restrictive group at 
T2 and T3 than in the high liberal group [84 (70–92) beats/min 
vs 68 (60–83) beats/min, p = 0.002 and 79 (72–92) beats/min 
vs 69 (60–81) beats/min, p = 0.012, respectively].
hemodynamic changes in Ci, sVi, 
and sVRi
Changes in CI values are shown in Figure 3A. In the restric-
tive group, CI significantly decreased from T0 to T1, T2, and 
T3 [2.9 (2.4–3.3) L/min/m2 vs 2.35 (1.93–2.78) L/min/m2 
and 2.2 (1.8–2.5) L/min/m2, p , 0.001; and 2.9 (2.4–3.3) L/
min/m2 vs 2.3 (1.93–3.07) L/min/m2, p = 0.002]. In the low 
liberal group, CI significantly decreased from T0 to T1 and 
T2 [2.65 (2.35–3.08) L/min/m2 vs 2.3 (2–2.68) L/min/m2 
and 2.2 (1.8–2.68) L/min/m2, p , 0.001]. CI did not change 
significantly in the high liberal group at any time point. 
The CI value was significantly lower in the restrictive group 
at T1 than in the high liberal group at the same time point 
[2.35 (1.93–2.78) L/min/m2 vs 2.8 (2.2–3.1) L/min/m2, 
p = 0.007].
Changes in SVI values are illustrated in Figure 3B. SVI 
values decreased significantly from T0 to T1, T2, and T3 in 
the restrictive group [38.5 (32–45.8) mL/m2 vs 27.5 (21–32.5) 
mL/m2, 27 (22–33.8) mL/m2 and 30 (24–37.8) mL/m2, 
p , 0.001] and from T0 to T1, T2, and T3 in the low liberal 
group [38 (30–43) mL/m2 vs 31 (27–33) mL/m2 and 29.5 
(24–33.8) mL/m2, p , 0.001] and [38 (30–43) mL/m2 vs 
34 (28–38) mL/m2, p = 0.015]. In the high liberal group, 
SVI values significantly increased from T0 to T1, T2, 
and T3 [39 (33–41) mL/m2 vs 52 (35–61) mL/m2, 48.5 
(34–56.8) mL/m2 and 52.5 (39–63) mL/m2, p , 0.001]. At 
T1, T2, and T3, the SVI values in the restrictive group were 
found to be significantly lower than those in the high liberal 
group [27.5 (21–32.5) mL/m2, 27 (22–33.8) mL/m2 and 30 
(24–37.8) mL/m2 vs 52 (35–61) mL/m2, 48.5 (34–56.8) mL/m2 
and 52.5 (39–63) mL/m2, p , 0.001; Figure 3B].
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Figure 2 Box-whisker diagram representing the dynamic changes of saP (A), DaP (B), MaP (C) and hR (D) before induction of anesthesia (), immediately after intubation 
( ), when pneumoperitoneum was created (||), and immediately after surgery (═) in the restrictive, low liberal, and high liberal groups.
Notes: The line within the box represents median value, whereas the outer margins of the boxes represent the interquartile range, and the “whiskers”, the range. levels of 
statistical significance are marked as follows: *p , 0.017 within the restrictive group, low liberal group, and high liberal group; #p , 0.025 between the restrictive group and 
the low liberal group; and $p , 0.025 between the restrictive and high liberal groups.
Abbreviations: SAP, systolic blood pressure; DAP, diastolic blood pressure; MAP, mean arterial pressure; HR, heart rate.
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SVRI values are illustrated in Figure 3C. SVRI signifi-
cantly increased in the restrictive group from T0 to T1 and 
T2 [2,453 (2,153–3,073) to 3,038 (2,378–3,541) and 3,278 
(2,836–4,628) dyn*s−1cm−5m−2, p , 0.001] and to T3 [2,843 
(2,353–3,498) dyn*s−1cm−5m−2, p = 0.013]. These values 
increased in the low liberal group from T0 to T2 [2,631 
(2,135–3,303) vs 3,200 (2,461–4,003) dyn*s−1cm−5m−2, 
p = 0.003]. SVRI values did not change significantly within 
the high liberal group.
Comparison of laboratory values
ABG and lactate values in arterial blood revealed no signs of 
global hypoperfusion or elevated lactate levels (Table 2).
Consumption of anesthetics
The calculated consumption of volatile anesthetic (sevo-
flurane, in milliliters) in the restrictive group was 34.4 
(30.6–46) mL, whereas it was 46 (38.2–46) mL in the low 
liberal group and 46 (46–53.5) mL in the high liberal group. 
There was a statistically significant difference between the 
restrictive and low liberal groups (p = 0.017) and between 
the restrictive and high liberal groups (p , 0.001).
The average consumption of opioid fentanyl was 150 
(100–200) µg in the restrictive group, whereas it was 175 
(150–250) µg in the low liberal group and 150 (150–200) µg 
in the high liberal group. There was significantly lower 
consumption of fentanyl in the restrictive, than in the low 
liberal, group (p , 0.009).
The average consumption of thiopental was 400 
(350–400) mg in the restrictive group, whereas it was 350 
(300–400) mg in the low liberal group and 400 (300–450) mg 
in the high liberal group. There were no statistically significant 
differences in thiopental consumption between all groups.
The average consumption of rocuronium bromide in the 
restrictive and the high liberal groups was 50 (50–60) mg, 
and it was 50 (50–50) mg in the low liberal group. There were 
no statistically significant differences in the consumption of 
rocuronium bromide between the groups.
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Figure 3 Box-whisker diagram representing the dynamic changes of the cardiac index (Ci) (A), sVi (B), and sVRi (C) before induction of anesthesia (), immediately after 
intubation ( ), when the pneumoperitoneum was created (||), and immediately after surgery (═) in the restrictive, low liberal, and high liberal groups.
Notes: The line within the box represents median value, while the outer margins of the boxes represent the interquartile range and the “whiskers”, the range. levels of 
statistical significance are marked as follows: *p , 0.017 within the restrictive group, low liberal group, or high liberal group; There was no statistically significant difference 
between the restrictive group and the low liberal group; and $p , 0.025 between the restrictive group and the high liberal group.
Abbreviations: CI, cardiac index; SVI, stroke volume index; SVRI, systemic vascular resistance index.
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safety and cost-effectiveness of a restrictive dose of crystalloids
The average consumption of Ringer’s solution in the 
restrictive group was 99 (73–113) mL, whereas it was 
474 (393–602) mL in the low liberal group and 1,485 
(1,222–1,970) mL in the high liberal group. There was signifi-
cantly lower consumption of Ringer’s solution between the 
restrictive and the low liberal groups (p , 0.001) and between 
the restrictive and the high liberal groups (p , 0.001).
The costs of the average consumption of sevoflurane 
in the restrictive group were €11 (9.8–14.7), whereas it 
was €14.7 (12.2–14.7) in the low liberal group and €14.7 
(14.7–17.1) in the high liberal group. The overall costs 
of sevoflurane consumption were €440 (392–588) in the 
restrictive group, €588 (488–588) in the low liberal group, 
and €588 (588–684) in the high liberal group.
The costs of the average consumption of fentanyl were 
€0.41 (0.27–0.54) in the restrictive group, €0.47 (0.41–0.68) 
in the low liberal group, and €0.41 (0.41–0.54) in the high 
liberal group. The overall costs of fentanyl consumption were 
€16.4 (10.8–21.6) in the restrictive group, €18.8 (16.4–27.2) 
in the low liberal group, and €16.4 (16.4–21.6) in the high 
liberal group.
The costs of the average consumption of thiopental were 
€0.72 (0.63–0.72) in the restrictive group, €0.63 (0.54–0.72) 
in the low liberal group, and €0.72 (0.54–0.81) in the high 
liberal group. The overall costs of thiopental consump-
tion were €28.8 (25.2–28.8) in the restrictive group, €25.2 
(21.6–28.8) in the low liberal group, and €28.8 (21.6–32.4) 
in the high liberal group.
The costs of the average consumption of rocuronium 
bromide were €4.4 (4.4–5.3) in the restrictive and high 
liberal groups, whereas in the low liberal group they were 
€4.4 (4.4–4.4). The overall costs of rocuronium bromide 
consumption were €176 (176–212) in the restrictive and 
high liberal groups, whereas in the low liberal group they 
were €176 (176–176). The costs of the average consumption 
of Ringer’s solution were €0.2 (0.15–0.23) in the restrictive 
group, €1 (0.8–1.2) in the low liberal group, and €3 (2.4–3.9) 
in the high liberal group. The overall costs of Ringer’s solu-
tion consumption were €8 (6–9.2) in the restrictive group, 
€40 (32–48) in the low liberal group, and €120 (96–156) in 
the high liberal group. The costs of sevoflurane consumption 
in the restrictive group were €148 cheaper than in the low 
and high liberal groups, and the consumption of fentanyl 
was only €2.4 cheaper in the restrictive group than in the low 
liberal group. The costs of Ringer’s solution consumption 
were €32 cheaper in the restrictive than in the low liberal 
group and €112 cheaper in the restrictive than in the high 
liberal group. The costs of anesthetics and crystalloids were 
€180 cheaper in the restrictive group than in the low liberal 
group and were €260 cheaper in the restrictive group than 
in the high liberal group.
Mortality and morbidity assessment
We found no statistically significant differences in the SAPS 
II score among the groups, but predictive mortality was 
significantly lower in the restrictive group than in the high 
liberal group [2.9% (1.4%–4.2%) vs 5.2% (3.8%–9.5%), 
p , 0.001; Table 3]. The 1-year mortality rate was 0% in all 
three groups, but there were some differences in morbidity. 
There were no statistically significant differences in early 
postoperative surgical complications, with one complication 
in each of the three groups. Postoperatively prolonged bile 
secretion by abdominal drainage was observed in the restric-
tive and high liberal groups without signs of inflammation, 
but with prolonged hospitalization (8 days in the restrictive 
group and 14 in the high liberal group). These were treated 
conservatively. Prolonged hospitalization of 15 days was 
observed in the low liberal group and was associated with 
inflammation; it was treated conservatively with antibiotics 
and resolved spontaneously. In addition, critical outcomes 
were observed, with one case of pulmonary congestion as a 
consequence of heart failure in the high liberal group in the 
early postoperative period as a direct consequence of the high 
volume load. Moreover, we analyzed the 1-year morbidity 
and found no statistically significant differences between 
the groups. In the restrictive group, we observed a case of 
acute pancreatitis with sepsis and another case of choledo-
cholithiasis with obstructive jaundice, which was treated by 
endoscopic retrograde cholangiopancreatography (ERCP) 
and sphincterotomy. In the low liberal group, an episode of 
heart failure was observed 4 months postoperatively and was 
determined to be unrelated to the surgery. The two cases of 
choledocholithiasis with obstructive jaundice were resolved 
by ERCP, sphincterotomy, and endobiliary stent implanta-
tion. In the high liberal group, we observed a case of bile 
reflux gastritis and another of stomach cancer 10 months 
after the cholecystectomy that required a subtotal gastrec-
tomy. Furthermore, a single case of Klatskin tumor or hilar 
cholangiocarcinoma was observed in the high liberal group. 
Cholangiocarcinomas tend to grow slowly and infiltrate 
the walls of the ducts, growing along tissue planes. Local 
extension occurs into the liver, porta hepatis, and regional 
lymph nodes of the celiac and pancreaticoduodenal chains. 
Further, life-threatening infection (cholangitis) that requires 
immediate antibiotic intervention and aggressive biliary 
drainage may occur.
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Discussion
The major finding of this study was that global hemody-
namics were preserved in the restrictive group, despite the 
negative intraoperative fluid balance, and there was no evi-
dence of activated anaerobic metabolism. Moreover, global 
hemodynamics were preserved in the low and high liberal 
groups. MAP did not significantly change after inducing 
pneumoperitoneum in any group – a finding that contrasts 
with the results of a previous study by Joris et al,15 in which 
the MAP increased after a pneumoperitoneum was created. 
The CI decreased after the induction of anesthesia and the 
creation of pneumoperitoneum in the restrictive and the 
low liberal groups, but it did not change in the high liberal 
group. The decreases in CI were likely the results of the 
reduced preload and the effects of pneumoperitoneum.15 
Pneumoperitoneum causes caval compression, an increase 
in venous resistance, and pooling of blood in the periphery 
of the circulatory system.15 SVI decreased after the induc-
tion of anesthesia, creation of pneumoperitoneum, and 
extubation within the restrictive and low liberal groups, 
whereas it significantly increased within the high liberal 
group. The volume load was larger in the high liberal group 
and, according to the Frank–Starling law, there was, there-
fore, a greater stretching of the myocardium, resulting in 
larger end-diastolic volume and greater SVI.16 The SVRI 
significantly increased after induction, creation of pneu-
moperitoneum, and extubation in the restrictive group, 
and after creation of the pneumoperitoneum in the low 
liberal group. The increase in SVRI can be attributed to 
a release of vasopressin and catecholamines.17 In the high 
liberal group, SVRI did not significantly change after the 
pneumoperitoneum was created because the large volume 
load prevented a preload reduction after the creation of the 
pneumoperitoneum. According to Joris et al,15 hemody-
namic changes induced by the pneumoperitoneum can be 
attenuated by increasing the cardiac filling pressures before 
peritoneal insufflation (by fluid loading and tilting the 
patient to the head-up position only after insufflation).
The effects of various doses of infusion solutions have 
been previously described, mostly in major abdominal 
operations. We focused on minimally invasive laparoscopic 
surgery, wherein the fluid loss is significantly lower and 
the restrictive doses of infused solutions were adequate 
to compensate for the invisible losses of perspiration and 
urination.2
We used Ringer’s solution7 to compensate for fluid 
losses and to maintain global hemodynamics during surgery. 
Unlike colloids, which stay in the circulation longer after 
Table 2 laboratory data of arterial blood gas values and lactate concentrations at four time points
Restrictive group Low liberal group High liberal group
T0 T1 T2 T3 T0 T1 T2 T3 T0 T1 T2 T3
ph 7.42 (7.39–7.43) 7.4 (7.37–7.42)* 7.3 (7.29–7.35)* 7.4 (7.38–7.41)* 7.41 (7.39–7.42) 7.4 (7.37–7.43)* 7.33 (7.29–7.35)* 7.38 (7.36–7.4)* 7.41 (7.39–7.43) 7.4 (7.37–7.42)* 7.33 (7.29–7.34)* 7.4 (7.38–7.41)*
pCO2 (kPa) 5.2 (4.9–5.5) 5.4 (5.1–6.15)* 6.4 (5.8–7.2)* 4.9 (4.7–5.2) 5.5 (5.2–5.9) 5.5 (5.1–5.8) 6.35 (5.9–7.6)* 5.1 (4.7–5.3)* 5.4 (5.1–5.7) 5.5 (5.1–5.9) 6.6 (5.9–7.2)* 4.9 (4.6–5.2)*
pO2 (kPa) 11.6 (10.7–13) 18.1 (14–22.5)* 12.15 (10.3–17.5) 12 (10.3–13.8) 11.7 (9.6–13.4) 17.7 (14.3–22.1)* 11.8 (9.8–13.2) 10.9 (9.1–13) 11.4 (9.6–13) 16.9 (13.5–20.9)* 11.7 (8.9–15.7) 10.9 (9.9–12.9)
hCO3 (mmol/l) 25 (23–26) 24.5 (23.3–26) 25 (23–26) 23 (21–24)* 25.5 (24–27) 25 (24–27) 25 (23–26) 22 (20–23)* 25 (23–26) 24.5 (24–26) 25 (23–26) 22 (20–23)*
Be (mmol/l) 0.5 (−1.0 to 2.0) 0 (−1.0 to 1.0)* −2 (−3.0 to −1.0)* −2 (−3.0 to −1.0)* 1 (−0.8 to 2.0) 0 (−1.0 to 2.0)* −2 (−3.0 to −0.3)* −3 (−4.0 to −1.0)* 0.5 (−1.0 to 2.0) 0 (−2.0 to 0.8)* −2 (−3.0 to −1.0)* −2 (−4.0 to −1.0)*
saO2 (%) 97 (96–98) 99 (98–99)* 96 (94–98) 97 (95–98) 97 (94–98) 99 (98–99)* 96 (94–97) 96 (94–98) 96 (94–98) 99 (97–99)* 96 (92–98) 96 (95–97)
lactates (mmol/l) 1.29 (1.1–1.75) 1.28 (1.1–1.5) 1.46 (1.25–1.72) 1.06 (0.9–1.32)* 1.2 (1–1.5) 1.1 (0.9–1.4) 1.4 (1.13–1.7) 1.04 (0.9–1.25)* 1.22 (1–1.84) 1.15 (0.95–1.46) 1.44 (1.12–1.67) 1 (0.86–1.26)*
Notes: Data are shown as median (25–75 percentiles range). Levels of statistical significance are marked as follows: *p , 0.017 compared with preoperative value within all 
groups; p , 0.025 compared between the restrictive and low liberal groups; and p , 0.025 compared between the restrictive and high liberal groups.
Abbreviations: pH, potential of hydrogen; pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen; HCO3, bicarbonates; BE, base excess; SaO2, arterial 
oxygen saturation.
Table 3 Simplified Acute Physiology Score (SAPS) and estimated mortality (%)
Restrictive group (n = 40) Low liberal group (n = 40) High liberal group (n = 40) p-values (p1/p2)
Median (IQR 25th–75th) 
(95% confidence interval)
Median (IQR 25th–75th)
(95% confidence interval)
Median (IQR 25th–75th)
(95% confidence interval)
saPs score 23 (19–23)
21–26.5
21 (13.5–26)
16–23
23 (20–29)
21–25.5
0.031/0.79
estimated 
mortality (%)
2.9 (1.4–4.2)
1.9–4.2
4.2 (1.5–7.2)
2.3–5.2
5.2 (3.8–9.5)
4.2–6.8
0.045/,0.001
Notes: Data are shown as median (25–75 quartiles range) and 95% confidence intervals. Levels of statistical significance are marked as follows: p1 , 0.025 refers to the 
restrictive group and low liberal group comparisons; p2 , 0.025 refers to the restrictive group and high liberal group comparisons.
Abbreviation: iQR, interquartile range.
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safety and cost-effectiveness of a restrictive dose of crystalloids
administration, only 20% of the infused volume of crystal-
loid solutions remains in circulation.3 Therefore, patients are 
usually given larger volumes of crystalloid solutions than 
of colloids during surgery. However, the infusion of large 
volumes of crystalloid solutions may lead to acute respira-
tory distress syndrome, pulmonary edema, brain edema, and 
abdominal compartment syndrome.18
Traditionally, the doses of infusion solutions admin-
istered during surgery have been more than the measured 
fluid losses incurred during tissue trauma or surgery. These 
liberal volumes are intended to compensate the loss of fluid 
from injured tissue and the vascular space, thus maintaining 
hemodynamic stability. The liberal volumes, moreover, are 
based on the premise that surgical patients are hypovolemic 
because of prolonged preoperative fasting and water depri-
vation, bowel cleansing, and invisible losses by perspiration 
and diuresis.3 It is now recommended, however, that patients 
consume solid food up to 6 hours and liquid up to 2 hours 
before a procedure.3 Further, it is known that the invisible 
losses due to perspiration are minimal, and the duration 
of preoperative fasting and water deprivation is short.3 
In thoracic surgery, the use of a restrictive dose of infusions 
has had a favorable effect on treatment outcomes.3 On the 
other hand, in patients who received larger volumes of infu-
sion solution for major colorectal surgery, significantly more 
postoperative complications were observed.3
There are no evidence-based guidelines describing the 
optimal volumes of perioperative fluid to be administered 
for surgical procedures. The ideal volume substitution is 
tailored to individual patients – an approach known as goal-
directed therapy,19 in which volume substitution is based on 
the patient’s hemodynamic values and tissue oxygenation.3 
This approach promptly compensates for losses from intra-
operative bleeding and invisible losses due to perspiration 
and diuresis.2 In comparative studies, no differences were 
found between restrictive or zero-balance fluid therapy and 
zero-balanced goal-directed therapy.9
A recent article published in the Cochrane database20 
suggests that restrictive fluid therapy is superior to a liberal 
fluid therapeutic strategy. In a multicenter study, Brandstrup 
et al21 investigated a homogenous collective of 172 patients 
undergoing major colorectal surgery.2,21 They demonstrated 
that perioperative intravenous fluid restriction (mean, 2,740 
vs 5,388 mL) significantly reduced the incidence of major 
and minor complications, such as anastomotic leakage, 
pulmonary edema, pneumonia, and wound infection.2,21 
Despite the administration of limited fluid and a perioperative 
decrease in urine output, acute renal failure did not occur in 
any patient.2,21 Although their analysis did not purely compare 
liberal versus restrictive, a close look at the infusion protocols 
reveals that, with regard to colloids versus crystalloids, they 
administered mainly colloids to the restrictive group whereas 
treating the liberal group with more than 5 L of crystalloids.2 
Their study was conducted in patients who underwent major 
colorectal surgery,21 whereas ours investigated patients who 
underwent laparoscopic cholecystectomy and we used only 
crystalloids. We chose a continuous dose of crystalloids 
because the dose was adequate to compensate for the losses 
in the low and the high liberal groups without the need for 
additional fluid boluses. In the restrictive group, the dose 
of 1 mL/kg/hr was sufficient to compensate for losses from 
insensible perspiration and diuresis. We assumed that the 
surgical losses would be low enough that the postoperative 
infusions could compensate for them. In case of hypotension, 
we would administer the vasopressor ephedrine, which was 
required in four patients in the restrictive group. We have 
omitted additional fluid boluses in the restrictive group to 
provide equal conditions across all three groups (continuous 
dose of crystalloids). Cost-effective analyses of the anes-
thetic regimens and anesthetic consumption have become 
Table 2 laboratory data of arterial blood gas values and lactate concentrations at four time points
Restrictive group Low liberal group High liberal group
T0 T1 T2 T3 T0 T1 T2 T3 T0 T1 T2 T3
ph 7.42 (7.39–7.43) 7.4 (7.37–7.42)* 7.3 (7.29–7.35)* 7.4 (7.38–7.41)* 7.41 (7.39–7.42) 7.4 (7.37–7.43)* 7.33 (7.29–7.35)* 7.38 (7.36–7.4)* 7.41 (7.39–7.43) 7.4 (7.37–7.42)* 7.33 (7.29–7.34)* 7.4 (7.38–7.41)*
pCO2 (kPa) 5.2 (4.9–5.5) 5.4 (5.1–6.15)* 6.4 (5.8–7.2)* 4.9 (4.7–5.2) 5.5 (5.2–5.9) 5.5 (5.1–5.8) 6.35 (5.9–7.6)* 5.1 (4.7–5.3)* 5.4 (5.1–5.7) 5.5 (5.1–5.9) 6.6 (5.9–7.2)* 4.9 (4.6–5.2)*
pO2 (kPa) 11.6 (10.7–13) 18.1 (14–22.5)* 12.15 (10.3–17.5) 12 (10.3–13.8) 11.7 (9.6–13.4) 17.7 (14.3–22.1)* 11.8 (9.8–13.2) 10.9 (9.1–13) 11.4 (9.6–13) 16.9 (13.5–20.9)* 11.7 (8.9–15.7) 10.9 (9.9–12.9)
hCO3 (mmol/l) 25 (23–26) 24.5 (23.3–26) 25 (23–26) 23 (21–24)* 25.5 (24–27) 25 (24–27) 25 (23–26) 22 (20–23)* 25 (23–26) 24.5 (24–26) 25 (23–26) 22 (20–23)*
Be (mmol/l) 0.5 (−1.0 to 2.0) 0 (−1.0 to 1.0)* −2 (−3.0 to −1.0)* −2 (−3.0 to −1.0)* 1 (−0.8 to 2.0) 0 (−1.0 to 2.0)* −2 (−3.0 to −0.3)* −3 (−4.0 to −1.0)* 0.5 (−1.0 to 2.0) 0 (−2.0 to 0.8)* −2 (−3.0 to −1.0)* −2 (−4.0 to −1.0)*
saO2 (%) 97 (96–98) 99 (98–99)* 96 (94–98) 97 (95–98) 97 (94–98) 99 (98–99)* 96 (94–97) 96 (94–98) 96 (94–98) 99 (97–99)* 96 (92–98) 96 (95–97)
lactates (mmol/l) 1.29 (1.1–1.75) 1.28 (1.1–1.5) 1.46 (1.25–1.72) 1.06 (0.9–1.32)* 1.2 (1–1.5) 1.1 (0.9–1.4) 1.4 (1.13–1.7) 1.04 (0.9–1.25)* 1.22 (1–1.84) 1.15 (0.95–1.46) 1.44 (1.12–1.67) 1 (0.86–1.26)*
Notes: Data are shown as median (25–75 percentiles range). Levels of statistical significance are marked as follows: *p , 0.017 compared with preoperative value within all 
groups; p , 0.025 compared between the restrictive and low liberal groups; and p , 0.025 compared between the restrictive and high liberal groups.
Abbreviations: pH, potential of hydrogen; pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen; HCO3, bicarbonates; BE, base excess; SaO2, arterial 
oxygen saturation.
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increasingly important in an attempt to reduce the costs of 
healthcare systems. A study by Smith et al22 compared the 
costs of inhalational anesthesia using sevoflurane with those 
of total intravenous anesthesia (TIVA) with propofol, and 
balanced anesthesia induced with propofol and maintained 
with sevoflurane. The primary variable studied was the cost 
of the anesthetic drugs (including wastage) and disposable 
equipment. After re-evaluation of the data from that study 
based on the current prices of propofol at the institution 
where the research was conducted, TIVA was found to be 
significantly less expensive than inhalational or balanced 
anesthesia.22 Vomiting occurred in 17% patients in the sevo-
flurane group and in none of the patients in the intravenous 
group; however, in the propofol plus sevoflurane group, 9% 
experienced vomiting.22 The simplest method for determin-
ing the cost of a particular anesthetic is to simply calculate 
drug consumption, perhaps including drug wastage and the 
cost of disposable equipment.23 In our study, we measured 
only the actual consumption of anesthetics and crystalloids 
but not drug wastage. Nausea and vomiting followed by 
incisional pain were found to be the most distressing factors 
for the postoperative patient and affect the cost necessary 
to ensure patient satisfaction.23 Furthermore, they have an 
impact on the time spent in the recovery room and will, 
therefore, influence the personnel costs associated with the 
anesthetic.23 Various studies have shown that intravenous 
techniques were associated with a significantly lower inci-
dence of postoperative nausea and vomiting as compared 
with the inhalational technique.23 Intravenous anesthesia 
with propofol has been shown to result in a shorter period of 
sick leave than anesthesia with thiopental and isoflurane.23 
In our study, all groups received balanced anesthesia with 
thiopental and sevoflurane and analgesia with fentanyl, and 
we did not compare the cost-effectiveness of each form of 
anesthesia, but rather the consumption of anesthetics and 
crystalloids according to the various volumes of Ringer’s 
solution. With regard to the 1-year postoperative morbidity, 
we would like to highlight a case of gastric carcinoma that 
occurred within a year of cholecystectomy. Kang et al’s24 
retrospective study mentioned that the possibly increased risk 
of stomach cancer in patients undergoing gallstone cholecys-
tectomy might be due to a duodenogastric bile reflux, and 
that the survival of these patients was poor.24 Therefore, close 
follow-up strategies for early detection are recommended for 
such patients.24 Despite the zero mortality rate in our study, 
the predictive mortality calculated by the SAPS II score 
was significantly higher in the high liberal group than in the 
restrictive group, and both cases of carcinoma (gastric and 
cholangiocarcinoma) were observed in that group. The inci-
dence of gastric and cholangiocarcinoma in patients in the 
high liberal group could not be explained by hypervolemia, 
and it seems that this observation is the result of additional 
cofactors such as multiple genetic and epigenetic alterations 
in oncogenes, impairment of DNA repair and tumor sup-
pressor genes, or dysregulation of cell-cycle regulators or 
signaling molecules that can, at least partially, be induced 
by the pro-inflammatory response caused by surgery and 
anesthesia in susceptible patients.25,26
There are some limitations to this study. The sample size 
was small and further analysis should be undertaken in a 
larger number of the patients undergoing low-risk, minimally 
invasive surgery such as laparoscopic cholecystectomy. 
Whether the results of our study will apply to more extensive 
operations deserves future study.
Conclusion
Global hemodynamics were preserved in all three groups, 
and there were no signs of global hypoperfusion or activated 
anaerobic metabolism in the restrictive or liberal groups. The 
consumption of anesthetics and Ringer’s solution was more 
cost-effective in the restrictive group than in the low liberal 
and high liberal groups. There were no statistically sig-
nificant differences between the groups with regard to early 
postoperative surgical complications, as well as the length of 
hospitalization and 1-year morbidity. These results confirm 
the rationale and safety of restrictive dose infusions during 
minimally invasive surgery (laparoscopic cholecystectomy) 
in low-risk patients and may not be applicable to all patients 
or surgical procedures.
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